DBV Technologies Screens First Infant in THRIVE Peanut Allergy Study
CHÂTILLON, France and WARREN, N.J., June 2026 DBV Technologies announced that the first participant has been screened in the...
food allergy
Advertisement
Mabylon Reports Positive Phase Ia MY006 Peanut Allergy Results
SCHLIEREN/ZURICH, Switzerland, May 19, 2026 Mabylon AG announced positive preliminary Phase Ia clinical data for its lead investigational therapy...
Novartis Acquires Excellergy in $2B Allergy Innovation Deal
Basel, Switzerland | March 27, 2026 Strategic Acquisition Strengthens Allergy Leadership Novartis has announced a major strategic move to...
GSK Acquires RAPT in $2.2B Bet on Food Allergy Therapy
London, United Kingdom, January 21, 2026 — GSK has announced a $2.2 billion acquisition of RAPT Therapeutics, securing global...
Advertisement
